Results 171 to 180 of about 136,474 (201)
Emerging technologies and vulnerabilities in older adults with cognitive impairments: a systematic review of qualitative evidence. [PDF]
BMC GeriatrSanchini V +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
CMT-conductivity-modulated transistor
IEEE Transactions on Electron Devices, 1992The characteristics of a conductivity-modulated transistor which can control AC current are presented. Measured characteristics of a fabricated device are shown and compared with calculated characteristics. Calculations are based on a physical, one-dimensional analytical model which has been, in part, derived from numerical analysis of the device.
B.M. Wilamowski, T.J. Englert
openaire +1 more source
SPIE Proceedings, 1986
Avalanche photodiodes (APD) based on bulk grown Cd0.7Hg0.3Te ( λ = 1.55 µm) offer significant advantages over the diodes fabricated from group III-V and group IV semiconductors. Metal Organic Chemical Vapour Deposition (MOCVD) is a well established technique for the growth of CMT (CdxHgl-xTe ...
G. T. Jenkin +4 more
openaire +1 more source
Avalanche photodiodes (APD) based on bulk grown Cd0.7Hg0.3Te ( λ = 1.55 µm) offer significant advantages over the diodes fabricated from group III-V and group IV semiconductors. Metal Organic Chemical Vapour Deposition (MOCVD) is a well established technique for the growth of CMT (CdxHgl-xTe ...
G. T. Jenkin +4 more
openaire +1 more source
Neurology, 2003
To determine whether Charcot-Marie-Tooth (CMT) with pyramidal features is genetically distinct from other dominantly inherited axonal neuropathies, the authors examined all chromosomal loci and genes for axonal CMT. Two families were identified with an axonal CMT phenotype with distal wasting, weakness, pes cavus, sensory loss, and mild pyramidal signs
S. Vucic +5 more
openaire +1 more source
To determine whether Charcot-Marie-Tooth (CMT) with pyramidal features is genetically distinct from other dominantly inherited axonal neuropathies, the authors examined all chromosomal loci and genes for axonal CMT. Two families were identified with an axonal CMT phenotype with distal wasting, weakness, pes cavus, sensory loss, and mild pyramidal signs
S. Vucic +5 more
openaire +1 more source
Current opinion in investigational drugs (London, England : 2000), 2004
CMT-3 is an orally active matrix metalloprotease inhibitor, and one of a series of inhibitors of multiple proteases and cytokines, under development by CollaGenex. The compound is currently undergoing phase II trials for the potential treatment of cancer, in particular metastatic cancer and HIV-related Kaposi's sarcoma.
openaire +1 more source
CMT-3 is an orally active matrix metalloprotease inhibitor, and one of a series of inhibitors of multiple proteases and cytokines, under development by CollaGenex. The compound is currently undergoing phase II trials for the potential treatment of cancer, in particular metastatic cancer and HIV-related Kaposi's sarcoma.
openaire +1 more source